CiteFacts · FDA Drug Shortages · FDA source
FDA shortage status: Furosemide Oral Solution
FDA source answer
FDA currently lists this ingredient in shortage.
FDA source statuses: Current. First FDA posting: 2026-03-31. Latest FDA row update: 2026-09-18.
FDA lists 3 package records, with companies: Hikma Pharmaceuticals USA Inc., Hikma Pharmaceuticals USA, Inc.. Package NDCs: 0054-3294-46, 0054-3294-50, 0054-3298-63.
FDA shortage reason: Shortage of an inactive ingredient component
This is nationwide FDA status, not local pharmacy inventory. CiteFacts does not provide medical, treatment, substitution, or dosing advice.
FDA package and manufacturer records
| Company | Package NDC | Presentation | FDA availability field | FDA update |
|---|---|---|---|---|
| Hikma Pharmaceuticals USA, Inc. | 0054-3294-46 | Furosemide, Oral Solution, 10 mg/1 mL (NDC 0054-3294-46) | Available | 2026-09-18 |
| Hikma Pharmaceuticals USA, Inc. | 0054-3294-50 | Furosemide, Oral Solution, 10 mg/1 mL (NDC 0054-3294-50) | Limited Availability | 2026-09-18 |
| Hikma Pharmaceuticals USA, Inc. | 0054-3298-63 | Furosemide, Oral Solution, 40 mg/5 mL (NDC 0054-3298-63) | Available | 2026-09-18 |
Source facts
Grouped generic ingredient: Furosemide Oral Solution · 3 package records
Therapeutic categories: Cardiovascular
Dosage forms: Oral Solution
Routes: ORAL
Open FDA source data · JSON · Markdown
FDA is authoritative. Source retrieved 2026-10-06T18:55:41+00:00. Derived grouping is documented in this record's derivations.